title: Serum lipids and arterial plaque load are altered independently with high-dose progesterone in hypercholesterolemic male rabbits.
abstract: Antiatherogenic effects of sex steroids in premenopausal women are not well defined. Therefore, we employed an established rabbit model for atherosclerosis to study the effects of exogenous estrogen and a progesterone analogue (P) on serum lipids and aortic plaque load. Serum cholesterol (C) and triglyceride (T) levels and atherosclerotic plaque loads were compared in 5 groups of male New Zealand White rabbits fed a 12-week, C-rich diet: 1 control group (CG) and 4 groups treated with estriol (E), haloperidol (H), low-dose 17-hydroxyprogesterone (LDP), or high-dose 17-hydroxyprogesterone (HDP). Serum P was measured in the LDP and HDP groups. Serial histologic sections (15 each of 27 ascending aortas) were studied by light microscopy and computerized morphometric analysis. Plaque load is defined as the ratio of intimal area to medial area (I/M). Exogenous E (p<0.001), H (P = 0. 02), LDP and HDP (P<0.001, each) were found to be significantly associated with less aortic plaque load than controls. In a multivariate analysis, after controlling for the differences in serum C and T levels, HDP (p = 0.014) was found to be associated with less aortic plaque load than controls, and this association approached statistical significance in the E (p = 0.052) and H (p = 0.069) groups. These data suggest that the mechanism(s) involved with the antiatherogenic effect of HDP in this animal model is, or are, independent of an alteration in serum lipids.
authors.affiliation: Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. houser.stuart@mgh.harvard.edu
authors.forename: S L
authors.initials: SL
authors.lastname: Houser
authors.forename: H T
authors.initials: HT
authors.lastname: Aretz
authors.forename: W C
authors.initials: WC
authors.lastname: Quist
authors.forename: Y
authors.initials: Y
authors.lastname: Chang
authors.forename: A D
authors.initials: AD
authors.lastname: Schreiber
mesh_terms: D019326:17-alpha-Hydroxyprogesterone / Q000008:administration & dosage*; D000818:Animals; D001011:Aorta / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D002784:Cholesterol / Q000097:blood*; D002791:Cholesterol, Dietary / Q000008:administration & dosage; D003324:Coronary Artery Disease / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D004036:Diet, Atherogenic; D004305:Dose-Response Relationship, Drug; D004964:Estriol / Q000008:administration & dosage; D006220:Haloperidol / Q000008:administration & dosage; D006937:Hypercholesterolemia / Q000097:blood* / Q000209:etiology / Q000473:pathology; D007091:Image Processing, Computer-Assisted; D008297:Male; D011817:Rabbits; D014280:Triglycerides / Q000097:blood*
chemical_list: D002791:Cholesterol, Dietary; D014280:Triglycerides; D019326:17-alpha-Hydroxyprogesterone; D002784:Cholesterol; D004964:Estriol; D006220:Haloperidol